Ugovi subcutaneous injection 1.0 mg SD, manufactured by Novo Nordisk Pharma, contains Semaglutide (genetical recombination). This medicine is indicated for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity. It is provided as a 1mg 0.5mL 1 kit with YJ code 2499418G7026.
Ugovi subcutaneous injection 1.0 mg SD
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →